(0.07%) 5 473.19 points
(0.10%) 39 153 points
(0.38%) 17 785 points
(0.11%) $80.92
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.25%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.67%) $10.67
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom...
Stats | |
---|---|
今日成交量 | 2 149 |
平均成交量 | 20 409 |
市值 | 39.14M |
EPS | $0 ( Q2 | 2023-09-30 ) |
下一个收益日期 | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.930 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-27 | Cerrone Gabriele M | Buy | 70 071 | Ordinary Shares |
2023-10-23 | Cerrone Gabriele M | Buy | 499 468 | Ordinary Shares |
2023-09-15 | Brancaccio John P | Buy | 16 670 | Ordinary Shares |
2022-05-19 | Cerrone Gabriele M | Buy | 5 800 000 | Ordinary Shares |
2022-05-19 | Jacob Gary S | Buy | 12 500 | American Depositary Shares |
INSIDER POWER |
---|
100.00 |
Last 18 transactions |
Buy: 8 086 209 | Sell: 58 400 000 |
OKYO Pharma Limited 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
OKYO Pharma Limited 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-3 797.00 (0.00 %) |
EPS: | $-0.600 |
FY | 2023 |
营收: | $0 |
毛利润: | $-3 797.00 (0.00 %) |
EPS: | $-0.600 |
FY | 2022 |
营收: | $0 |
毛利润: | $-2 423.01 (0.00 %) |
EPS: | $-0.00550 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.290 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OKYO Pharma Limited
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。